Home›Stock Screener›Hemant Surgical Industries›Financial Statements

Hemant Surgical Industries Complete Financial Statements

2 Years of Data
2026 - 2025

In FYNone, Hemant Surgical Industries (HSIL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 8.2% and ROE of 13.8%. Full financial statements from FY2025 to FY2026 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Check HSIL market capitalization to track the company's total market size over time.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.19% 2026 data
EBITDA Margin 9.91% 2026 data
Operating Margin 10.00% 2026 data
Return on Assets 6.93% 2026 data
Return on Equity 13.77% 2026 data

Balance Sheet Ratios

Current Ratio 48.00 2026 data
Equity Ratio 50.36% 2026 data
Asset Turnover 0.85 2026 data

HSIL Revenue, Net Profit & EBITDA — Year-on-Year Growth

HSIL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see HSIL screener.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+85.1%
Year-over-Year
Equity Growth
+119.0%
Year-over-Year

HSIL Income Statement — Revenue, EBITDA & Net Profit

Hemant Surgical Industries revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 8.2%. View HSIL 52-week chart for the annual high/low range and current price position.

Periods ₹ Crores
Particulars None March 2026 March 2025
Revenue 0 232 112
Expenses 0 209 98
EBITDA 0 23 14
Operating Profit Margin % 0.00% 10.00% 8.00%
Depreciation 0 2 1
Interest 0 4 2
Profit Before Tax 0 24 11
Tax 0 4 2
Net Profit 0 19 8
Earnings Per Share (₹) 0.00 15.39 7.70

HSIL Balance Sheet — Assets, Liabilities & Shareholders' Equity

HSIL total assets ₹274 Cr, total equity ₹138 Cr, total liabilities ₹ Cr (2026) — ROE 13.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025
ASSETS
Total Assets 274 148
Current Assets 192 89
Fixed Assets 54 40
Capital Work in Progress 0 12
Investments 59 0
Other Assets 0 97
LIABILITIES
Total Liabilities
Current Liabilities 4 24
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 138 63
Share Capital 13 10
Reserves & Surplus 125 53

HSIL Cash Flow Statement — Operating, Investing & Financing

Hemant Surgical Industries operating cash flow ₹9 Cr, investing ₹-30 Cr, financing ₹18 Cr, net cash flow ₹-4 Cr (2025).

Periods ₹ Crores
Particulars March 2025
Operating Activities 9
Investing Activities -30
Financing Activities 18
Net Cash Flow -4